Imperial Recognized as 2025 Best & Brightest Company to Work For in West Michigan! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Tag:

Midsize BioPharma CMOs

    Life-Science EventsPatient Recruitment and Retention

    Talking Recruitment with Small/Mid BioPharm CMOs at CMO Summit – West

    by Dan McDonald November 12, 2015
    written by Dan McDonald

    I had the honor of attending and presenting at the CMO Summit – West earlier this week in Burlingame, CA. Attended by 75-80 industry executives – primarily consisting of Chief Medical Officers, heads of clinical development and leaders from the financial community – the CMO Summit is an intimate and dynamic forum for discussion of the challenges facing today’s medical leaders from small to mid size bio-pharmaceutical companies.

    My presentation focused on the current trends in patient recruitment impacting today’s CMOs and specifically, how these individuals are addressing the challenge of on time enrollment in their clinical trials. In fact, there is probably no group that I have worked with over the years who are under more pressure than the CMO from a small/mid-sized sponsor, who is working under a VC backed financing structure.

    Yet, despite many of the investments in these firms being heavily time and cost milestone driven, we still see too many of these decision makers being reluctant to implement proactive patient recruitment campaigns. The result often being delayed trials, significant budgetary impact and a boatload of stress.

     

    Certainly, over my 16 years in patient recruitment, I have seen a sea-change in the mindset of sponsors when it comes to recruitment. In fact, when I first started out, about 80% of the programs I worked on were rescue/reactive type situations. Today, more than 60% of the recruitment programs are proactive. This is major progress, but it’s been far too slow.

    DAC has analyzed the behavior of CMOs and C-teams from small/mid sponsors who meet their enrollment timelines. We have also compared the cost differences between proactive recruitment programs and reactive ones.

    My presentation at the CMO Summit- West covered these issues and more. Please let me know if you are interested in receiving a copy of the slides. For CMOs and C-Suite teams at small/mid sponsors, I would welcome the opportunity to schedule a web-conference and present the same material to you. Just shoot me a message with your availability.

    November 12, 2015 0 comment
    0 FacebookTwitterLinkedinEmail

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    See Do Get

    August 12, 2014
  • 2

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    Clinical Trial Supply Chains: The Key to Avoiding Disruptions

    May 10, 2022

Categories

  • Ancillary Trial Supplies and Equipment (28)
  • Business Insights (124)
  • Clinical Trial Writing and Design (36)
  • Life-Science Events (50)
  • Patient Engagement (30)
  • Patient Recruitment and Retention (93)
  • Site Materials & Logistics (44)
  • Study Site Management (21)
  • Translation of Study Materials (17)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribe to our blog and get the latest updates, insights, and industry trends delivered straight to your inbox. Stay informed and never miss a post.